THE SKINNY  
 
  OBAGI-C RX® – SYSTEM – The Early Intervention System
from the Winter 2010 issue

Obagi-C® RX System is designed for younger skin – women and men ages 18 to 40. The system corrects the early signs of aging and environmental skin damage, while preventing future damage and protecting the beautiful young skin you already have.

Young skin is usually great skin – it's vibrant and supple with a youthful glow. But if your young skin is starting to show signs of environmental damage – sun, smoke and pollutants, such as little freckles, age spots and your first fine wrinkles, then it’s time to take action to correct emerging signs of aging before they become visible. Even if you've taken steps to protect your skin, moisturizing and spot treating isn't enough. We have seen amazing results and recommend the Obagi-C® Rx Early Intervention System.

What is the Obagi-C Rx Early Intervention System?

The Obagi-C Rx System is a complete skin-care program that proactively corrects early signs of damage to help restore and maintain your healthy, youthful skin. It’s the only system offering the benefits of both prescription-strength hydroquinone and potent vitamin C in one comprehensive package. So, you don't have to spend time and money piecing together the components you need to ensure your young skin stays that way.

What does the Obagi-C Rx System do?

The Obagi-C Rx System addresses the following needs of young skin:

1. Corrects hyperpigmentation (discoloration)—evens skin tone and enhances color uniformity—by regulating the production of the cells responsible for pigment in your skin;
2. Promotes skin cell turnover through gentle exfoliation with vitamin-C to expose more glowing, healthy skin; and
3. Helps prevent future skin cell damage by neutralizing free radicals and protecting the skin from UVA (aging) rays and UVB (burning rays).
   


For a free consult on the Obagi-C Rx System, call one of our aestheticians at The SPA at 713.850.0470.
 
 
 
WELCOME SERVICES THE SKINNY APPOINTMENTS PRODUCTS ABOUT US CALENDAR CLINICAL TRIALS CONTACT US